ESSA Pharma Inc. Net Promoter Score 2020 Benchmarks

Estimated Net Promoter Score is

-8

EPI-001 is a novel experimental non-steroidal antiandrogen that is under investigation for the treatment of prostate cancer. The drug is being developed by the pharmaceutical company ESSA Pharma Inc and is currently in pre-clinical development.

EPI-001 is an antagonist of the androgen receptor of the AR and blocking protein-protein interactions required for transcriptional activity of the AR and its splice variants of the AR and competitively block binding and activation of the receptor by androgens. Due to its unique mechanism of action, EPI-001 may prove to be effective in the treatment of advanced prostate cancer resistant to conventional antiandrogens such as enzalutamide.

As of 2016, EPI-001's successor, EPI-506, is under clinical investigation in a phase I/II study.

What is Net Promoter Score?

NPS is a customer loyalty metric that measures customers’ willingness to not only return for another purchase or service but also make a recommendation to their family, friends or colleagues.

It is a powerful and effective technique, which can greatly increase a company's revenue if used properly.

The main advantages of NPS are close correlation with a company's growth and easy collection, interpretation and communication of the data.

Learn more about NPS

Is ESSA Pharma Inc.'s estimated NPS of -8 considered to be good?

Net Promoter Score is a number from -100 from 100.

Scores higher than 0 are typically considered to be good and scores above 50 are considered to be excellent.

The industry average for Health Care / Major Pharmaceuticals is 0.

Browse NPS benchmarks

How to understand the NPS benchmarks

The final Net Promoter Score of a company strongly depends on a context in which the satisfaction is measured.

Consider an example: If ESSA Pharma Inc. sends out NPS surveys immediately after purchase, they are tracking their customers' initial excitement and the checkout experience.

On the other hand, if they survey their customers a few weeks after the purchase they are also tracking how satisfied their customers are with their products and services over time.

Therefore, comparing the NPS score of ESSA Pharma Inc. with your own without any further context is not that useful.

What is extremely useful though, is using the NPS methodology to track the satisfaction of your customers over time. That's where Customer.guru comes in.

What is Customer.guru? Why is useful?

After successfully using Net Promoter Score for our own e-commerce projects,
 we have decided to let anyone benefit from what we've learned.



We have founded Customer.guru in 2016 to help e-shops, SaaS services and startups better understand their customers, improve their services and increase their revenues.

Customer.guru is an easy-to-setup tool for tracking segmented customer satisfaction using Net Promoter Score.

Learn more

Other companies with Net Promoter Score similar to ESSA Pharma Inc.

Company Industry Score
McDonald's Consumer Brands / Fast Food -8
Tesco Consumer Brands / Grocery -8
US Airways Travel and Hospitality / Airlines -8
marks & spencer Consumer Brands / Grocery -10
NatWest Business Banking Financial Services / Banking -6
Virgin Media Telecommunications / Cable/TV service -6
Amazon Prime Consumer Brands / Entertainment -11
Ziggo Telecommunications / Other -11
Golomt Bank Financial Services / Banking -11
Time Warner Telecommunications / Cable/TV service -5

We have estimated the Net Promoter Score of ESSA Pharma Inc. based on the publicly available information
including the sentiment of the company-related tweets, 3rd party reviews, and Alexa ratings.

Do you think this information is incorrect? Report incorrect information. Do you have more accurate data? Submit NPS score.